As at Nov 21, 2024, the EXEL stock has a PE ratio of 22.04. This is based on the current EPS of $1.58 and the stock price of $34.83 per share. A decrease of 20% has been recorded in the P/E ratio compared to the average of 27.4 of the last 4 quarters.
The mean historical PE ratio of Exelixis over the last eight years is 57.25. The current 22.04 PE ratio is 62% below the historical average. In the past eight years, EXEL's PE ratio was at its highest in the Mar 2017 quarter at 722.33, with a price of $21.67 and an EPS of $0.03. The Dec 2018 quarter recorded the bottom point at 8.48, with a price of $19.67 and an EPS of $2.32.
Maximum annual increase: 235.44% in 2020
Maximum annual decrease: -85.49% in 2018
Year | PE ratio | Change |
---|---|---|
2023 | 36.91 | 31.17% |
2022 | 28.14 | 12.38% |
2021 | 25.04 | -55.09% |
2020 | 55.75 | 235.44% |
2019 | 16.62 | 95.99% |
2018 | 8.48 | -85.49% |
2017 | 58.46 | N/A |
2016 | N/A | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
EXEL's current P/E ratio is lower than the 3, 5 and 10-year averages.
EXEL's PE ratio is lower than its peer stocks JNJ and AMGN, but it is greater than MRK's. Exelixis's current PE ratio of 22.04 is below the average of its peers, which is 29.11.
Stock name | PE ratio | Market cap |
---|---|---|
MRK Merck & Co Inc | 20.85 | $252.61B |
EXEL Exelixis Inc | 22.04 | $9.95B |
JNJ Johnson & Johnson | 25.79 | $374.39B |
PFE Pfizer Inc | 33.07 | $142.41B |
AMGN Amgen Inc | 36.74 | $155.83B |
BMY Bristol Myers Squibb Co | N/A | $118.1B |
CRIS Curis Inc | N/A | $34.71M |
EXEL stock has a price to earnings ratio of 22.04 as of Nov 21, 2024.
The 3-year average PE ratio for EXEL stock is 31.97.
The 5-year average PE ratio for EXEL stock is 37.5.
In the last eight years, the Mar 2017 quarter recorded the highest quarterly PE ratio at 722.33.
EXEL's current price to earnings ratio is 62% below its 8-year historical average.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Nov 21, 2024), Exelixis's stock price is $34.83. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.58. Therefore, Exelixis's P/E ratio for today is 22.04. PE RATIO(22.04) = STOCK PRICE($34.83) / TTM EPS($1.58)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.